Precision epigenetics provides a scalable pathway for improving coronary heart disease care globally

Author:

Broyles Damon12,Philibert Robert345ORCID

Affiliation:

1. Mercy Technology Services, St. Louis, MO 63127, USA

2. Mercy Precision Medicine, Chesterfield, MO 63017, USA

3. Department of Psychiatry, University of Iowa, Iowa City, IA 52242, USA

4. Cardio Diagnostics Inc, Chicago, IL 60642, USA

5. Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA

Abstract

Coronary heart disease (CHD) is the world’s leading cause of death. Up to 90% of all CHD deaths are preventable, but effective prevention of this mortality requires more scalable, precise methods for assessing CHD status and monitoring treatment response. Unfortunately, current diagnostic methods have barriers to implementation, particularly in rural areas and lower-income countries. This gap may be bridged by highly scalable advances in DNA methylation testing methods and artificial intelligence. Herein, we review prior studies of CHD related to methylation alone and in combination with other biovariables. We compare these new methods with established methods for diagnosing CHD. Finally, we outline pathways through which methylation-based testing methods may allow the democratization of improved methods for assessing CHD globally.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Genetics

Reference73 articles.

1. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations

2. CDC: Office of Policy, Performance, and Evaluation. Health topics – heart disease and heart attack. www.cdc.gov/policy/polaris/healthtopics/heartdisease/index.html

3. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: results from the Global Burden of Disease Study 2017

4. Leeder S, Raymond S, Greenberg H, Liu H, Esson K. A race against time: the challenge of cardiovascular disease in developing economies. Columbia University, NY, USA (2004).

5. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3